Related by context. All words. (Click for frequent words.) 74 Aplidin R 72 YONDELIS 72 PSMA ADC 72 liposomal formulation 72 pan HDAC inhibitor 72 GRNVAC1 72 AAG geldanamycin analog 72 Aplidin 71 preclinical efficacy 71 MAGE A3 ASCI 71 AKT inhibitor 71 Liposomal 71 vinorelbine tartrate 70 oral prodrug 70 fosbretabulin 70 Tarceva TM 70 vinca alkaloid 70 histone deacetylase HDAC inhibitor 70 targeted antifolate 70 Hsp# Inhibitor 70 GW# [003] 70 depsipeptide 70 IMiDs R 70 solithromycin 70 Aflibercept 70 Degarelix 70 indibulin 69 M1 muscarinic 69 prucalopride 69 Omacetaxine 69 pharmacologically active isomer 69 subcutaneously administered 69 orally dosed 69 Kinase Inhibitor 69 bortezomib Velcade 69 PDE4 inhibitor 69 bevacizumab Avastin R 69 orally administered inhibitor 69 busulfan 69 selective antagonist 69 neuronal nicotinic receptor NNR 69 Epratuzumab 69 BAL# [002] 69 YONDELIS R 69 radiolabeled 69 mertansine 69 potent topoisomerase II 69 DAVANAT 69 KB# [002] 69 interleukin IL -# 69 isatoribine 69 HQK 69 demonstrated antitumor activity 69 rxRNA 69 targeting CD# 69 Pharmacodynamic 68 Elvitegravir 68 Luteinizing Hormone Releasing Hormone 68 evaluating tivozanib 68 metaglidasen 68 Alfacell proprietary ribonuclease 68 IMiDs ® 68 CYT# potent vascular disrupting 68 selective kinase inhibitor 68 RAV# 68 non nucleoside inhibitor 68 pharmacokinetic PK study 68 Bayer HealthCare Onyx Pharmaceuticals 68 Safinamide 68 Cloretazine ® 68 Cytochrome P# 68 trabectedin 68 Recombinant Human 68 cetuximab Erbitux R 68 selective orally bioavailable 68 Onconase 68 HepDirect prodrug 68 BEZ# 68 aurora kinase inhibitor 68 polyglutamate 68 galiximab 68 liposomal doxorubicin 68 mesylate 68 HuMax EGFr 68 vapreotide acetate 68 ZOLINZA 68 investigational humanized monoclonal antibody 68 targeted radiotherapeutic 68 IL# PE#QQR 68 NN# [001] 68 chimeric monoclonal antibody 68 IAP inhibitor 68 histone deacetylase inhibitor 68 Guanilib 68 huN# DM1 68 PKC# 68 Temsirolimus 68 SUTENT ® 68 HuMax CD4 68 Dalbavancin 68 Cloretazine 68 accumulate preferentially 68 MKC# MKC# PP 68 relapsed MM 68 resolvin 68 ENMD # 68 docetaxel Taxotere R 68 Belerofon 68 Pharmacokinetics PK 68 CANCIDAS 68 highly selective endothelin 68 immune modulatory 68 multicenter Phase II 68 intranasal formulation 68 Talabostat 68 OvaRex R 68 Iloperidone 68 Silodosin 68 polymerase inhibitor 68 CDK inhibitor 68 dose proportionality 68 maximally tolerated dose 68 potent suppressor 68 anti CD3 68 telomerase therapeutic 67 Pazopanib 67 receptor tyrosine kinase inhibitor 67 PRTX 67 DEB# 67 5alpha reductase 67 Novolimus 67 hepatoma 67 potently inhibits 67 oral picoplatin 67 motesanib diphosphate 67 SinuNase ™ 67 protein tyrosine phosphatase 1B 67 sorafenib Nexavar 67 T#I [002] 67 Pemetrexed 67 plasmid encoding 67 HGS ETR2 67 Qutenza TM 67 Teriflunomide 67 LB# [003] 67 HGS ETR1 mapatumumab 67 flavopiridol 67 MGd 67 MVA MUC1 IL2 67 oral treprostinil 67 thalidomide Thalomid 67 Initiate Phase 67 antibody MAb 67 Lenocta 67 GLP toxicology studies 67 intravesical instillation 67 pharmacodynamic properties 67 Ziprasidone 67 small molecule tyrosine 67 PrevOnco 67 IMiDs ® compound 67 5 HT2A serotonin 67 PSN# [002] 67 IMA# 67 Valortim ® 67 immunoconjugate 67 Anti Tumor 67 Sym# 67 syngeneic 67 topically administered 67 Zorbtive TM 67 orally bioavailable 67 DUROS 67 TLR agonists 67 Gleevec resistant 67 SAR# [004] 67 luteinizing hormone releasing 67 Panzem R NCD 67 teriflunomide 67 TKB# 67 dose escalation clinical 67 oral antiviral 67 dasatinib Sprycel 67 selective agonist 67 novel histone deacetylase 67 PEGylated interferon 67 ADVANCE PD 67 Phase IIA 67 vitro cytotoxicity 67 docetaxel Taxotere ® 67 erlotinib Tarceva ® 67 Melphalan 67 5 Fluorouracil 67 pegylated liposomal doxorubicin 67 volociximab 67 tumorigenicity 67 Initiated Phase 67 Kinoid 67 iobenguane 67 Yondelis ® 67 KSP inhibitor 67 Kuvan sapropterin dihydrochloride 67 huC# DM4 67 memantine HCl 67 IMP# 67 Meets Primary Endpoint 67 cyclic peptide 67 Azacitidine 67 TLR9 agonist 67 Mg Usa 67 PD LID 67 Tyrima 67 nilotinib Tasigna 67 proteasome inhibitor 67 myelofibrosis polycythemia vera 67 antisense inhibition 67 gemcitabine Gemzar ® 67 peptidomimetic 67 JAK inhibitor 67 Pivotal Phase III 67 cannabinor 67 sunitinib Sutent ® 67 beta 1a 67 somatostatin analogue 67 Parathyroid Hormone 67 potent cytotoxic 67 Elotuzumab 67 receptor inhibitor 67 #beta estradiol 67 Pharmacokinetic PK 67 Prolongs Survival 67 Phase 2b Clinical Trial 67 tubulin inhibitor 67 highly selective inhibitor 67 Myocet 67 RhuDex ® 67 Xcellerated T Cells 67 Alocrest 67 Pimavanserin 66 Androgel R 66 Anticalins ® 66 midstage clinical 66 cathepsin K inhibitor 66 Bendamustine 66 Ixabepilone 66 epigenetic therapies 66 Fulvestrant 66 ceftazidime 66 Xanafide 66 trastuzumab DM1 T DM1 66 GVAX ® 66 doxorubicin cyclophosphamide 66 RAF kinase 66 Sapacitabine 66 ESBA# 66 Proellex TM 66 Janus Kinase 66 Novel Oral 66 Tesetaxel 66 kidney urologic 66 Aurora Kinase 66 CCX# 66 potent anticancer 66 Carfilzomib 66 novel peptide 66 Mg Uk 66 murine monoclonal antibody 66 non nucleoside HCV 66 ZK EPO 66 Annexin V 66 Enzastaurin 66 tumor xenograft models 66 Novel Antibiotic 66 Ostabolin C TM 66 Bosutinib 66 CLORETAZINE TM VNP#M 66 pentostatin 66 PI3K/Akt pathway inhibitor 66 Multiple Myeloma MM 66 IIa clinical 66 PEG SN# 66 Fenretinide 66 subcutaneous immunoglobulin 66 nucleoside analog 66 adult mesenchymal stem 66 anti angiogenic agent 66 subcutaneous SC 66 Antiangiogenic 66 R#/MEM # 66 Phase Ib study 66 CYP#A# CYP#D# 66 Angiotensin Converting Enzyme 66 HDAC Inhibitor 66 Metastatic Melanoma 66 Phase Ib II 66 Removab 66 anti CD3 antibody 66 Arno Therapeutics 66 orally inhaled 66 PENNVAX B 66 REMINYL ® 66 EndoTAG 66 Pertuzumab 66 Vitaxin 66 mda 7 66 Apoptone 66 ospemifene 66 BRIM2 66 Zalypsis 66 Thiovir 66 antimitotic 66 HGS# 66 Trandolapril 66 Mycophenolate Mofetil 66 meropenem 66 GTC recombinant human 66 5HT 66 TIMP 1 66 MVA HPV IL2 66 DepoVax TM 66 Preclinical Study 66 Sudhir Agrawal D.Phil 66 samalizumab 66 octreotide acetate 66 Anticalin ® 66 5 HT2C 66 MEK inhibitor 66 Pharmacokinetic Study 66 microtubule inhibitor 66 CBLC# 66 RiVax 66 Isavuconazole 66 gefitinib Iressa 66 Bortezomib 66 Interferon alfa 66 Antiviral Activity 66 Quinamed 66 Randomized Phase 66 HuMax 66 Sanofi Pasteur Fluzone 66 immunotoxin 66 nucleotide analog 66 Antigenics QS 66 alvespimycin 66 vivo preclinical 66 MT# MEDI 66 alefacept 66 cisplatin resistant 66 CEQ# 66 p# biomarker 66 BMS# 66 intratumoral injection 66 mecamylamine 66 HCV replicon 66 Sipuleucel T 66 benzimidazole 66 Decitabine 66 selective adenosine 66 prostanoid 66 Deforolimus 66 Blinatumomab 66 hyaluronidase enzyme 66 CD# monoclonal antibody 66 Antigen Specific 66 SAR# [002] 66 MAb 66 lenalidomide Revlimid R 66 novel VDA molecule 66 Cancer Res 66 Rigel R# 66 Tesamorelin 66 Tezampanel 66 Tipranavir 66 Monoclonal antibody 66 cromolyn sodium 66 arsenic trioxide injection 66 Vidofludimus 66 acyclovir Lauriad R 66 Immunotherapeutic 66 AEGR 66 Nucleoside 66 Myolimus 66 humanised monoclonal antibody 66 long acting muscarinic 66 R Saizen R 66 neratinib 66 Thiarabine 66 histamine dihydrochloride 66 humanised antibody 66 blinded randomized placebo controlled 66 antitumoral 66 monoclonal antibody mAb 66 Enhanze Technology 66 OMP #M# 66 Phase Ib clinical trials 66 calcitonin gene related 66 LAB CGRP 66 eligen 66 DNA intercalator 66 cortisol synthesis 66 synthetic siRNA 66 AEG# 66 favorable pharmacokinetic profile 65 ART# 65 Nitazoxanide 65 #I TM# 65 CRLX# 65 JVRS 65 radezolid 65 Cytotoxic 65 PF # [002] 65 Factor VIIa 65 Dose Ranging Study 65 lexidronam injection 65 EXPAREL TM 65 Azedra 65 Secretase 65 Leuprolide 65 selective modulator 65 Antiviral Therapy 65 papillary renal cell carcinoma 65 neurokinin 1 65 Darinaparsin 65 DermaVir Patch 65 Orally administered 65 Talotrexin 65 basal bolus regimen 65 sodium glucose cotransporter 65 Monoclonal 65 pegylated recombinant 65 proprietary polysaccharide 65 somatostatin analog 65 Mipomersen 65 Tocilizumab 65 NS5B polymerase 65 NP2 65 NOD SCID mice 65 Ophena 65 Cardiotoxicity 65 Dasatinib 65 Aliskiren 65 PEG IFN 65 Systemic Delivery 65 Arranon 65 colon carcinoma 65 hA# 65 Pafuramidine 65 DermaVir 65 Iluvien TM 65 NB S# strontium malonate 65 potent antiproliferative 65 Aeolus Pharmaceuticals Announces 65 Traficet EN 65 Ozarelix 65 IMiD 65 vascular disrupting agents 65 PRT# 65 Alkeran 65 rFSH 65 Afatinib 65 rhMBL 65 oral tyrosine kinase 65 taxane derivative 65 PEGPH# 65 RhuDex TM 65 sorafenib tablets 65 DGAT 65 Tyrosine Kinase Inhibitor 65 Captisol Enabled 65 Taxol ® 65 Anidulafungin 65 Tumor Response 65 Vidaza azacitidine 65 Pathway Inhibitor 65 Romidepsin 65 NeuroSTAT ® 65 Enkephalin 65 uricase 65 Cathepsin S 65 monoclonal antibody conjugated 65 Cannabinor 65 Annamycin 65 XOMA 3AB 65 nanomolar range 65 MTP inhibitor 65 selective androgen receptor modulator 65 acetonide FA 65 Oral NKTR 65 Capesaris 65 Methylnaltrexone 65 phase Ib 65 5 HT6 receptor 65 Trastuzumab DM1 65 ATL# [001] 65 SGLT 65 EXPLORE Xa 65 virus AAV 65 Irinotecan 65 monoclonal 65 Myelodysplastic Syndrome MDS 65 Olaparib 65 imatinib Gleevec ® 65 Vaxfectin TM adjuvant 65 intravesical infusion therapy 65 paclitaxel poliglumex 65 JAK Inhibitor 65 anti amnesic 65 PHX# 65 peripherally acting 65 Trofex 65 LT NS# 65 Triapine R 65 biliary tract cancer 65 sitaxsentan 65 Epirubicin 65 torezolid 65 thrombin receptor 65 alpha#beta# integrin 65 Ceflatonin R 65 directed radiotherapeutic antibody 65 hypoxia inducible factor 65 Glufosfamide 65 RhuDex 65 liposomal amphotericin B 65 immunomodulator 65 Maribavir 65 TransVax tm 65 Velcade bortezomib 65 retaspimycin 65 Phase #b/#a clinical 65 Polyphenon R 65 IFN g 65 Exherin TM 65 MKC# MT 65 oral Janus kinase 65 beta2 agonist 65 Granulocyte Colony Stimulating Factor 65 Panzem R 65 BiTE R 65 K ras mutations 65 MT#/MEDI-# 65 BARACLUDE R 65 bispecific 65 Calcium Acetate 65 Gamunex C 65 topoisomerase II inhibitor 65 macrolide antibiotic 65 Amrubicin 65 Alkaline Phosphatase 65 Valortim R 65 Romiplostim 65 CIMZIA ™ 65 Oral Insulin 65 receptor blocker 65 GHRH 65 INSPIRE Trial Phase III 65 Phase III Pivotal 65 cilengitide 65 EZN 65 IMPDH inhibitor 65 diarrhea predominant irritable 65 Leukine ® 65 carboxypeptidase 65 Linaclotide 65 nucleotide analogue 65 Nanobody 65 Fc gamma receptor 65 #mg/#mg 65 Aclidinium 65 FOLFOX6 chemotherapy regimen 65 pharmacodynamic PD 65 virus HCV protease inhibitor 65 DCCR 65 Inhalation Powder 65 Sevelamer 65 embryonal carcinoma 65 Interferon alpha 65 Panzem 65 pharmacokinetics PK 65 Saxagliptin 65 HCV RNA polymerase 65 Omacetaxine mepesuccinate 65 MORAb 65 thymalfasin 65 potently inhibited 65 preclinically 65 novel immunotherapeutic 65 BioNumerik 65 pharmacokinetic PK 65 IL #E 65 S/GSK# 65 Oncogenic 65 ritonavir boosted 65 pomalidomide 64 initiated Phase Ib 64 dopamine D2 64 Multimeric 64 antineoplastic 64 effector function 64 Zemplar Capsules 64 Antitumor activity 64 mineralocorticoid receptor 64 TAKSTA 64 Anticancer Agent 64 pharmacokinetic PK profile 64 selectively inhibits 64 investigational immunotherapy 64 Cimzia ® certolizumab pegol 64 OHR/AVR# 64 Cethromycin 64 ongoing Phase 1b 64 paclitaxel Taxol ® 64 MKC# 64 TLK# 64 mononuclear 64 VEGFR2 inhibitor 64 itraconazole Sporanox 64 novel prodrug 64 PORxin TM platforms 64 Epothilones 64 Xeloda ® 64 deoxy 64 Peginterferon 64 Cariprazine 64 ZD# [001] 64 reslizumab 64 Janus kinase 64 small molecule Hedgehog 64 Pharmacokinetic studies 64 Monoclonal Antibody 64 RhuDex R 64 oral rivaroxaban 64 radiolabeled monoclonal antibody 64 ALN TTR# 64 gemcitabine cisplatin 64 PORxin TM 64 PDX pralatrexate 64 TRO# 64 bazedoxifene conjugated estrogens 64 Neulasta ® 64 methylnaltrexone bromide 64 chemokine receptor 64 IgG1 monoclonal antibody 64 ALB # 64 miconazole Lauriad ® 64 abacavir Ziagen 64 intranasal delivery 64 Squalamine 64 Triapine 64 Novel Inhibitor 64 Linagliptin 64 lenalidomide Revlimid 64 D aspartate NMDA receptor 64 Interferon Gamma 64 randomized controlled multicenter 64 Crit Rev 64 aurora kinase 64 Bezielle 64 NSABP B 64 RezularTM 64 selectively inhibited 64 Civacir 64 delta opioid receptor 64 somatostatin 64 Olmesartan 64 humanized antibody 64 RNAi Therapeutic 64 non nucleoside 64 BLP# Liposome Vaccine 64 albiglutide 64 urocortin 2 64 Polymerase Inhibitor 64 humanized anti 64 vesicular monoamine transporter 64 Adenoscan R 64 Medidur TM FA 64 peptibody 64 adecatumumab MT# 64 mTOR mammalian target 64 PET tracer 64 peptide fragment 64 UPLYSO 64 pharmacokinetic interactions 64 mITT population 64 irreversible inhibitor 64 Targretin capsules 64 preclinical pharmacokinetic 64 triciribine phosphate monohydrate 64 Preclinical studies suggest 64 antiangiogenic activity 64 HSP# inhibitor 64 ChronVac C 64 TG# [003] 64 zotarolimus 64 generation antisense inhibitor 64 MyoCell SDF 1 64 recombinant fusion 64 Junovan TM 64 antiproliferative activity 64 selective A2A adenosine receptor 64 Phase 1b clinical trials 64 Solazed 64 ActA 64 alkylating 64 Anti VEGF 64 Litx 64 Peptide YY 64 Xelox 64 virosome 64 Tindamax 64 generation purine nucleoside 64 radiotherapeutic 64 hematological tumors 64 refractory chronic lymphocytic 64 Alinia 64 gastrin analogue TT 64 histone deacetylase HDAC 64 panitumumab Vectibix 64 immune globulin intravenous 64 XL# XL# 64 cytokine refractory 64 Onalta 64 TÎ ² 4 64 lucinactant 64 Initiates Clinical 64 afamelanotide 64 vorinostat 64 cediranib 64 Protexia ® 64 Multiple Ascending Dose 64 using Crucell PER.C6 64 Chemophase 64 vaccine ChronVac C 64 phase IIa clinical 64 Eniluracil 64 INxin TM 64 retapamulin 64 5 HT2A inverse 64 Phase 2b Trial 64 lenalidomide Revlimid ® 64 dasatinib Sprycel ® 64 ABLYNX 64 Ophena TM 64 humanized monoclonal 64 immune modulating 64 Patients Treated With 64 nanopharmaceutical 64 MedPulser 64 5 fluorouracil leucovorin 64 Ceflatonin 64 paclitaxel Taxol R 64 Study Evaluating 64 Ceplene/IL-2 64 antibody blinatumomab MT#/MEDI-# 64 CCR5 mAb 64 fluoropyrimidine 64 Cetrorelix 64 Bone Morphogenetic Protein 64 imatinib resistant 64 #:#-# [020] 64 cinacalcet 64 TAFA# 64 THR beta agonist 64 Antitumor 64 hypoxia selective 64 carbohydrate polymer 64 novel immunomodulatory 64 Davanat 64 entinostat 64 HER1 64 Randomized Phase II 64 selective estrogen receptor modulator 64 Cutaneous T 64 CD# CEA 64 Aeroquin 64 pentamidine 64 Prodarsan ® 64 tumor specific antigen 64 TRAIL R2 64 SCIg 64 G#DT 64 bleomycin 64 CR# vcMMAE 64 Galantamine 64 epoetin delta 64 Ecallantide 64 personalized dendritic 64 Protein Kinase C 64 Inotek Pharmaceuticals Corporation 64 ALN HPN 64 mediated inhibition 64 HDACi 64 Anticalins R 64 acadesine 64 Elagolix 64 HER2 ErbB2 64 pegylated 64 Commences Phase 64 transgenic mouse models 64 #F FDG 64 IRX 2 64 ganetespib 64 TRAIL induced apoptosis 64 PYY #-# 64 TMC# C# 64 Soliris eculizumab 64 q8h 64 PEGylated 64 Antithrombin 64 trastuzumab Herceptin R 64 ARRY # 64 antisense inhibitor 64 PI3K Akt 64 NUVIGIL ® 64 lipopeptide 64 ONCONASE R 64 imexon 64 tigecycline 64 Voreloxin 64 topical gel formulation 64 CHARISMA trial 64 Dendritic Cells 64 EGFR HER2 64 Presents Preclinical Data 64 A3 adenosine receptor 64 Tubulin 64 Menadione 64 MAGE A3 64 pharmacokinetic pharmacodynamic 64 LymphoStat B belimumab 64 Teysuno 64 INCB# [001] 64 novel orally bioavailable 64 KNS # 64 tarenflurbil 64 pharmacodynamics PD 64 azilsartan medoxomil 64 PROSTVAC TM 64 Intradermal 64 LHRH receptor positive 64 Daclizumab 64 Archexin 64 Dacogen decitabine 64 GRN#L 64 PI3K/mTOR 64 Amplimexon 64 plus DOXIL 64 selective phosphodiesterase 64 peptide conjugated 64 thapsigargin 64 OncoVex 64 zoledronate 64 Tanespimycin 64 protein kinase inhibitor 64 Prodarsan R 64 EndoTAGTM 1 64 aspartyl 64 ADP receptor antagonist 64 Dapagliflozin 64 Micromet BiTE 64 Solorel TM 64 Recurrent Glioblastoma 64 Pralatrexate 64 Anavex #-# 64 Phase Ib clinical 64 Pyridorin TM 64 sublingual formulation 64 novel topoisomerase 64 Proc Am Soc 64 Darunavir 64 systemic RNAi therapeutic 64 VA# [002] 64 REG2 64 HDL Selective Delipidation 64 APOPTONE 64 microdose 64 DiLA2 64 anti CD3 monoclonal 64 PROCHYMAL 64 oxazolidinone 64 denileukin diftitox 64 LymphoStat B TM 64 IFN α 64 Pegylated 64 NTDDS 64 fluticasone furoate 64 Cloretazine VNP#M 64 HCV protease 64 AtherOx 64 PDE# inhibitors 64 pain palliation 64 apoptosis inducers 64 2 methoxyestradiol 64 metastatic malignant 64 Therapeutic Vaccine 64 mitogen activated ERK kinase 64 EGS# 64 lymphoid malignancies 63 sulfonylhydrazine class 63 NSCLC tumors 63 plasma kallikrein inhibitor 63 Initiates Enrollment 63 Clevudine 63 Neupogen ® 63 cynomolgus monkeys 63 Technosphere ® 63 isoenzyme 63 fusion enhancers 63 Axitinib 63 Immunomodulatory 63 Fluticasone 63 GMX# 63 ocular formulation 63 decitabine 63 cancer vaccine Norelin 63 florbetaben 63 defensin mimetic antibiotic 63 CELVAPAN H#N# 63 GAMMAGARD LIQUID 63 HCD# [002] 63 Pharmacokinetic 63 prasterone 63 hapten 63 Cloretazine R 63 oxaliplatin Eloxatin 63 pan histone deacetylase 63 IIa trials 63 Virulizin ® 63 cytotoxic T lymphocyte 63 OMP #R# 63 Pramlintide 63 Transfersome ® 63 Panzem NCD 63 EOquin TM 63 trastuzumab emtansine T DM1 63 polyclonal antibody 63 anticancer agent 63 immunoglobulin G 63 SCCHN 63 Lodamin 63 Small Molecule 63 Rotigotine 63 essential thrombocythemia ET 63 DNA demethylating agent 63 brand ciclesonide HFA 63 armodafinil Tablets C 63 BiTE 63 Alexza Staccato 63 ixabepilone 63 generation Hsp# inhibitor 63 milatuzumab 63 Vivaglobin 63 epothilones 63 Bevirimat 63 Zoraxel TM 63 Bazedoxifene 63 Hematopoietic 63 trivalent influenza vaccine 63 Gastrointestinal Stromal Tumors 63 OvaRex ® MAb 63 humanized therapeutic 63 phase IIa 63 injected subcutaneously 63 mTOR inhibitor 63 cyclin dependent kinase inhibitor 63 trastuzumab DM1 63 PTH analogue 63 Copegus ribavirin 63 antisense oligonucleotide 63 therapeutic monoclonal antibody 63 bovine thrombin 63 lorvotuzumab mertansine 63 hPTH #-# 63 Curaxin CBLC# 63 TAXOTERE R 63 mg kg BID 63 BENICAR HCT 63 daily subcutaneous injections 63 Adrenergic 63 Aganocide 63 mitomycin 63 Raltegravir 63 ARIKACE 63 Vaxfectin TM 63 sunitinib malate 63 Symadex 63 CYC# 63 ATPace TM 63 Crofelemer budesonide foam 63 agonistic human 63 diclofenac sodium 63 Piperacillin 63 PROSTVAC ® 63 BCIRG 63 Phase 1a clinical 63 Neuvenge 63 binds selectively 63 antiangiogenic therapy 63 Muraglitazar